Tue.Apr 30, 2024

article thumbnail

FTC targets Novo's Ozempic, others in crackdown on 300-plus 'junk' patent listings in FDA database

Fierce Pharma

The U.S. Federal Trade Commission (FTC) is not done with its crackdown on what it views as improper listing of patents with the FDA. | The U.S. FTC is not done with its crackdown on what it views as improper listing of patents in the FDA Orange Book. After an initial round of challenge launched in November against more than 100 patents, the FTC is back targeting another 300-plus patent listings by eight pharma firms.

FDA 313
article thumbnail

J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer

MedCity News

Enlaza Therapeutics’ drugs form covalent bonds that lock the therapy onto its target. With cancer as its initial focus, the startup contends its approach could offer safety and efficacy advantages compared to currently available targeted therapies. The post J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer appeared first on MedCity News.

Leads 123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits

Fierce Pharma

Biopharma companies and industry lobbying groups are striking out in their legal efforts to challenge price-cutting measures in the Inflation Reduction Act. | A federal judge tossed lawsuits by Bristol Myers Squibb and Johnson & Johnson, which questioned the constitutionality of the U.S. government requiring drugmakers to negotiate with Medicare on drug pricing.

Biopharma 307
article thumbnail

Momentum is Building to Put Medical Cannabis into Mainstream Healthcare 

MedCity News

The Drug Enforcement Agency’s decision to reclassify cannabis to a Schedule III drug could mark the first step in a long process to establish a new normal for medical cannabis care. The post Momentum is Building to Put Medical Cannabis into Mainstream Healthcare appeared first on MedCity News.

Medical 117
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks

Fierce Pharma

Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter. | Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter.

266
266
article thumbnail

Walmart retreats from healthcare, closing clinics across US

pharmaphorum

For the last few years, Walmart has been promising to disrupt the US healthcare sector with a national network of clinics providing low-cost care and telehealth services. Now, it is reining back on those plans.

More Trending

article thumbnail

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Adaeze Enekwechi, CEO of Cayaba Care

MedCity News

In this month’s episode, Senior Reporter Katie Adams explored some executive hires and exits that recently occurred in the healthcare world, as well as layoffs affecting the industry. She also interviewed Adaeze Enekwechi, who became CEO of Cayaba Care this month. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Adaeze Enekwechi, CEO of Cayaba Care appeared first on MedCity News.

article thumbnail

WuXi AppTec's CEO pledges to 'do the right thing' as sales slip following US biosecurity scrutiny

Fierce Pharma

With WuXi AppTec’s very existence under threat from proposed biosecurity legislation in the U.S., the Chinese CDMO giant is standing its ground on its quest to preserve its business and “do the rig | With WuXi AppTec’s very existence under threat from proposed biosecurity legislation in the U.S., the Chinese CDMO giant is standing its ground on its quest to preserve its business and “do the right thing,” the company’s CEO, Ge Li, said in the company’s first-quarter earnings report.

Sales 238
article thumbnail

CHMP meeting highlights: April 2024

European Pharmaceutical Review

The Committee for Human Medicinal Products (CHMP) has recommended the approval of new eight medicines. A positive opinion of a marketing authorisation was granted for Altuvoct (efanesoctocog alfa), as a treatment and prophylaxis of bleeding in patients with the rare blood disorder haemophilia A. Last week, the US FDA approved a new gene therapy for eligible adults with haemophilia B.

article thumbnail

UK's Centre for Process Innovation plots cloud-first manufacturing plant as part of digital collaboration with AZ, GSK and more

Fierce Pharma

UK's Centre for Process Innovation plots cloud-first manufacturing plant as part of digital collaboration with AZ, GSK and more fkansteiner Tue, 04/30/2024 - 10:01

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

ESCMID 2024: The infectious consequences of climate change

Pharmaceutical Technology

Dengue fever is now found in over 120 countries compared to nine that experienced severe epidemics in the 1970s given the spread of infectious diseases due to climate change.

98
article thumbnail

From viral vectors to nucleic acids: biopharma’s evolving manufacturing landscape

European Pharmaceutical Review

What are the top three trends that you are seeing in the biopharma manufacturing space? Vikas Gupta (VG): In the years preceding the Covid pandemic, the ATMP s market, including both the innovators as well as the contract development and manufacturing organisations (CDMOs), was a bit too optimistic about its growth prospects as it was building significant manufacturing capacity focusing primarily on viral vectors.

article thumbnail

California to sell state-branded Narcan generic to cut costs

pharmaphorum

California will start selling its own generic of overdose reversal agent naloxone in another example of the use of government-level purchasing power to reduce drug prices

article thumbnail

Accelerating spectroscopic analysis for data acquisition

European Pharmaceutical Review

Researchers in Germany have developed an technique to increase the speed of spectroscopic analysis , which typically takes from minutes to hours to acquire measurement. [the technique] can greatly accelerate data acquisition in ultrafast spectroscopy, particularly in higher-dimensional analyses” According to the paper published in the Journal of Ultrafast Science , the innovative technique “can greatly accelerate data acquisition in ultrafast spectroscopy, particularly in higher-dimensiona

Doctors 97
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Prime editing comes of age as FDA clears human trials

pharmaphorum

Prime Medicine has been given the go-ahead by the FDA for the first human trial of its prime editing technology, which promises to deliver one-shot therapies for a range of severe genetic diseases.

FDA 97
article thumbnail

Home Health: A Solution to Skyrocketing Healthcare Costs

MedCity News

A great deal of healthcare can take place in the home, leaving valuable bandwidth available for specialized facilities when they are needed. The post Home Health: A Solution to Skyrocketing Healthcare Costs appeared first on MedCity News.

article thumbnail

WHO proposes recommendations for preventing nitrosamine contamination

European Pharmaceutical Review

The World Health Organization (WHO) has published a new draft guidance on mitigating nitrosamine contamination in pharmaceutical products. Manufacturers of excipients and APIs should be compliant with relevant WHO good manufacturing practice (GMP) guidelines” One of the key recommendations described the actions manufacturers should take upon identifying a case of nitrosamine contamination that is above acceptable limits.

article thumbnail

Healthcare Moves: A Monthly Summary of Hires and Layoffs

MedCity News

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Precision Biosciences gets grant for engineered meganucleases for modifying human mitochondrial dna

Pharmaceutical Technology

Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.

article thumbnail

What’s Keeping Healthcare CIOs Up at Night: How Health Systems Automate Routine Phone Calls to Improve Workforce Effectiveness and Reduce Agent Burnout

MedCity News

With hospitals struggling to retain staff and value-based care shrinking healthcare revenues, health systems must look to technology resources to become more efficient, without losing sight of patient care or staff support. The post What’s Keeping Healthcare CIOs Up at Night: How Health Systems Automate Routine Phone Calls to Improve Workforce Effectiveness and Reduce Agent Burnout appeared first on MedCity News.

article thumbnail

Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer

Pharmaceutical Technology

The FDA granted accelerated approval for the drug back in September 2021 following positive Phase II trial data.

FDA 98
article thumbnail

Merck KGaA Financially Commits $322 Million Toward Research Center

Pharmaceutical Commerce

The complex will research solutions for manufacturing antibodies, mRNA applications, and more.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Cambridge study finds AI more accurately assesses eye problems compared to doctors

PharmaTimes

GPT-4 is trained on datasets to offer eye-related advice, diagnosis and management suggestions

Doctors 106
article thumbnail

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

PharmaTech

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

69
article thumbnail

MIT researchers find circadian rhythms in liver function influence drugs’ effectiveness

PharmaTimes

An estimated 50% of human genes follow a circadian cycle, many of which are active in the liver

94
article thumbnail

Travel Nursing Won’t Solve the Staffing Shortage, But Reimagining Staffing Models Might

MedCity News

Shift flexibility is critical to nurse satisfaction. The post Travel Nursing Won’t Solve the Staffing Shortage, But Reimagining Staffing Models Might appeared first on MedCity News.

60
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Pharma Pulse 4/30/24: Advocating For Weight Loss Medication, AI Start-Ups Face Rough Financial Reality Check & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Unlocking the Potential of Healthcare Claims Data Part I: Identifying Cost-Saving Opportunities 

Clarify Health

This is part one of our three-part series about how health plan leaders can leverage healthcare claims data to reduce costs , strategically grow their networks , provide best-in-class member services , and enhance outcomes for their members. R ising healthcare costs pressure health plans to find creative ways to reduce costs without compromising patient outcomes.

article thumbnail

Labor Day: More Than Just a Day Off

Contrarian Sales Techniques

Happy Labor Day! Today isn't just about snagging that last summer barbecue or hitting the beach—it’s about giving it up for the everyday heroes of the American workforce. Way back in the late 19th century, Labor Day started as a shout-out to the grunt and grind that built this country, and it's still a nod to the sweat that keeps it running. This holiday is our chance to kick back, sure, but it’s also the perfect time to tip our hats to the achievements of workers and the labor movement that’s f

Sales 52
article thumbnail

Manufacturing Sales Training: Key Strategies For Success

Spotio

Sales reps in the manufacturing industry face unique challenges. Competition is fierce, buyers often come to the table with preconceived notions—notions that must be adjusted to make sales—and prices continue to plummet in an attempt to win business. We’re here to tell you that success is possible in this space. But you need to train your reps to overcome the challenges in front of them and close deals.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A